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Ventricular Tachycardia Isthmus Sites
to Guide Ablation
An Approach in Evolution*Srinivas R. Dukkipati, MD, Javier Sanz, MDSEE PAGE 774T he mechanism of ventricular tachycardia(VT) in patients with structural heart diseaseis primarily scar-related reentry (1).
Although any disease process that results in the
formation of myocardial scar can predispose to
reentrant VT, the best characterized substrate is
post-myocardial infarction VT. After myocardial
infarction, ventricular tissue can be classiﬁed into 3
types: normal myocardium, dense scar, and the
intervening border zone (BZ). In the BZ, myocardial
ﬁbrils are interspersed between electrically inert
ﬁbrotic tissue causing electrical conduction to take a
circuitous path and, together with abnormal myocyte
cell-to-cell coupling, causes slow conduction, a
necessary component for reentrant VT (2). Electrical
conduction through these myocardial channels can
exit the scar and depolarize normal myocardium
resulting in 12-lead electrocardiogram morphology of
the VT that is dependent on the location of this exit
site. Myocardial channels are identiﬁed during VT
ablation on the basis of their abnormal conduction
properties, which yield fractionated and late
potentials and are incorporated in the ablation
strategy based on observations that they are strongly
associated with VT isthmus sites (3). Additionally,
pacing from within the BZ may identify a potential
VT isthmus site when the paced 12-lead QRS
morphology matches the VT. Although late potentials
and good pacemapping sites may denote potential VT
isthmus sites, their participation in any VT can only
be proven by entrainment maneuvers performed*Editorials published in JACC: Cardiovascular Imaging reﬂect the views
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paper to disclose.during tachycardia and by termination of VT during
ablation at the site (4). However, only a fraction of
patients will have exclusively hemodynamically
tolerated VT to allow detailed entrainment mapping.
Therefore, a substrate-based ablation strategy dur-
ing sinus or paced rhythm is commonly used.
This approach uses a 3-dimensional electroanatomic
mapping system that allows: 1) spatial localization
of a mapping catheter; 2) construction of a 3-
dimensional anatomic representation of a cardiac
chamber based on bipolar voltage information
recorded from the catheter tip to allow delineation of
normal and infarcted myocardium; and 3) cataloging
of potential VT isthmus sites identiﬁed by brief
entrainment, the presence of late potential, or good
pacemapping sites that are then targeted for ablation
(5). This process is not only tedious and time-
consuming, but electroanatomic mapping provides
a rather limited picture of the true extent of
myocardial scar that is restricted to the surface being
mapped (i.e., the endocardial or epicardial surface).
Information regarding the extent of intramyocardial
scar or scar on the opposing surface is not
obtained. Whether cardiac magnetic resonance (CMR)
can simplify this process by providing detailed
information regarding myocardial scar architecture is
under active investigation.In this issue of iJACC, Piers et al. (6) describe the
CMR characteristics of critical isthmus sites in 44
patients with ischemic and nonischemic cardio-
myopathy undergoing VT ablation. Critical isthmus
sites for 78 of 110 inducible VTs were identiﬁed based
on pacemapping in 67, concealed entrainment in 10,
and arrhythmia termination in 31 VTs. Critical sites
were then projected on 3-dimensional scar re-
constructions derived from pre-procedural CMR,
and local late gadolinium enhancement (LGE)
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786characteristics were analyzed. These included
transmurality, density (scar core and BZ deﬁned as
regions with signal intensity >50% and between 35%
and 50% of maximal myocardial signal intensity,
respectively), distance to the core-BZ transition, and
distance to areas with scar transmurality >75%.
Critical ablation sites were located within 5 mm of
>75% transmural scar in 74% to 100% of cases,
depending on the mapping criteria used, and within 5
mm of the core-BZ zone in 67% to 100%. Areas
fulﬁlling both CMR criteria contained all isthmus
sites deﬁned by concealed entrainment, 56% of those
deﬁned by pacemapping, and 77% of VT termination
sites.
The authors are to be congratulated for performing
a meticulous characterization of scar architecture, as
determined by LGE, of critical sites for VT ablation in
a sizable number of patients with both ischemic and
nonischemic cardiomyopathies. They demonstrate
that critical isthmus sites are often located in the
vicinity of areas with high degrees of scar trans-
murality, yet also limited scar density. Although these
ﬁndings may seem contradictory, they certainly are
not. Although the misleading term BZ may suggest a
region located at the scar periphery simultaneously
containing dense scar adjacent to normalmyocardium,
the CMR deﬁnition most often used based on signal
intensity rather than transmurality is more reﬂective
of interspersed ﬁbrotic and viable tissue across part
or all of the myocardial thickness. Given the spatial
heterogeneity of ischemic and nonischemic scar, its
characterization as a region with varying degrees of
ﬁbrosis transmurality and density throughout seems
much more realistic than an oversimpliﬁed view of
a compact core surrounded by less dense ﬁbrosis.
Then, the presence of BZ areas in any location within
the scar, including the core, is not unexpected. Indeed,
previous studies integrating LGE and electroanatomic
mapping have shown that conducting channels
and/or critical VT circuit regions often correspond to
areas with intermediate signal intensity locatedwithin
the near-transmural core of the scar (7–11). This is in
line with the ﬁndings of the present study of a pre-
dominant clustering of critical isthmus sites nearareas with >75% transmurality and/or the core-BZ
transition. This information may aid ablation pro-
cedures by guiding mapping preferentially to such re-
gions if scar architecture is known in advance. One
important question yet remains unanswered, specif-
ically, the diagnostic performance of the criteria pro-
posed by the authors for differentiating critical from
noncritical intrascar sites. Even though regions within
5 mm of >75% transmural scar and/or the core-BZ
interface are relatively conﬁned (i.e., only a median
of 13% of the left ventricular area in the present study
fulﬁlled both criteria), they still represent a sub-
stantial percentage of the total scar area (median, 24%
of the left ventricle). Thus, it is likely that many intra-
scar noncritical areas also demonstrate one or both
features. A comparison of the CMR characteristics of
critical isthmus sites with randomly selected, non-
critical regions would strengthen the study and help
to answer this question, and we certainly encourage
the authors to perform such an investigation.
This study further illustrates the potential role of
CMR to guide electrophysiological interventions.
Before it becomes a mainstream tool, consistency in
the methodology for scar core and BZ quantiﬁcation
will be needed. Previous deﬁnitions include the one
used by the authors using thresholds of 50% and 30%
of maximal signal intensity (12) or 60% and 40% (10),
or 3 and 2 SDs above normal myocardial signal (13). It
is also possible that performance may improve with
individualized threshold settings (10). Furthermore,
signal intensity is not only determined by tissue
characteristics but also by imaging variables such as
spatial resolution, contrast dose, and timing of
acquisition. With further standardization of imaging
protocols, CMR may perhaps facilitate identiﬁcation
of VT critical isthmuses in clinical practice, which
could result in reduced procedural duration and/or
an increased success rate.
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